SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

Position statement suggests despite conceptual concerns that protective immune responses to SARS-CoV-2 vaccination may be diminished in some patients with IBD, such as those taking anti-TNF drugs, the benefits of vaccination are likely to outweigh these theoretical concerns.

Source:

Lancet Gastroenterology and Hepatology